[Systemic lupus erythematosus and Epstein-Barr virus]
AbstractWe determined the prevalence of antibodies to Epstein-Barr virus [EBV] in 44 patients with systemic lupus erythematosus [SLE] and 44 healthy blood donors matched for sex and age as controls. Of the cases, 39 were women; mean age was 33 years. Four cases [9%] and 5 controls [11%] were positive for IgM anti-viral capsid antigen [VCA] [P = 0.9]. All the cases were positive for IgG anti-VCA compared with 91% of the controls [P = 0.12]. The mean immunity ratio for this antibody was 2.341 in cases and 1.873 in controls [P = 0.068]. Forty [91%] cases were positive for IgG anti-EBNA1 [EB nuclear antigen1] compared with 42 [95%] controls [P = 0.6]
Tazi, I., Fehri, S., Elghrari, K., Ouazzani, T. & Benchemsi, N. (2009). [Systemic lupus erythematosus and Epstein-Barr virus]. EMHJ - Eastern Mediterranean Health Journal, 15 (3), 701-708, 2009 http://www.who.int/iris/handle/10665/117688
JournalEMHJ - Eastern Mediterranean Health Journal, 15 (3), 701-708, 2009
MetadataShow full item record
Showing items related by title and MeSH subject.
Immunoinflammatory markers and disease activity in systemic lupus erythematosus: something old, something new Elwy, M.A.; Galal, Z.A.; Hasan, H.E. (2010)This study assessed the utility of some novel inflammatory markers compared with traditional laboratory markers in patients with systemic lupus erythematosus [SLE]. In a cohort of 43 SLE patients [19 with inactive and 24 with active SLE] and 20 healthy controls, serial measures of soluble vascular cell adhesion molecule [sVCAM-1] were significantly associated with SLE disease activity, scored using the British Isles Lupus Assessment Group index. Inflammatory markers neopterin and soluble intercellular adhesion molecule [sICAM-1] appeared to be ...